Log In
Print
BCIQ
Print
Print this Print this
 

SARS (D3252)

  Manage Alerts
Collapse Summary General Information
Company Protein Sciences Corp.
DescriptionSevere acute respiratory syndrome (SARS) vaccine comprised of purified recombinant spike protein from the SARS virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationSARS-associated coronavirus
Indication DetailsVaccinate against SARS virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today